CENTRAL LABORATORIES WHITE PAPERS & ARTICLES

• Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us

  Benchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.

• Expression Of Key Immunology Drug Targets In Human Inflammatory Challenge Models

  Human challenge models reveal immune pathway behavior in controlled settings, linking early research to outcomes and helping confirm target engagement, refine dosing, and reduce development uncertainty.

• Data Quality And Monitoring In Clinical Trials: Reducing Errors And Ensuring Compliance

  Clear data ownership and tailored reporting tools reduce errors and manual reconciliation, keeping trial data accurate and audit-ready.

• CRF Validation Best Practices: Building Reliable Clinical Trial Databases

  CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.

• Who Is Responsible When AI Helps Write The Consent Form?

  AI is reshaping consent materials, but accuracy, oversight, and transparency remain essential. As guidance evolves, organizations must balance innovation with accountability to protect participants.